SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5vgr'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K5Q_B_PACB559_0
(PENICILLIN G ACYLASE
ALPHA SUBUNIT
PENICILLIN G ACYLASE
BETA SUBUNIT)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 7 ALA A 350
TYR A 324
SER A 358
ALA A 356
None
0.90A 1k5qA-5vgrA:
undetectable
1k5qB-5vgrA:
undetectable
1k5qA-5vgrA:
17.41
1k5qB-5vgrA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WG8_A_SAMA3142_0
(PREDICTED
S-ADENOSYLMETHIONINE
-DEPENDENT
METHYLTRANSFERASE)
5vgr ATLASTIN-3
(Homo
sapiens)
5 / 12 THR A 261
GLY A 228
GLY A 227
GLY A 224
ASP A 233
None
1.19A 1wg8A-5vgrA:
undetectable
1wg8A-5vgrA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WG8_B_SAMB3141_0
(PREDICTED
S-ADENOSYLMETHIONINE
-DEPENDENT
METHYLTRANSFERASE)
5vgr ATLASTIN-3
(Homo
sapiens)
5 / 12 THR A 261
GLY A 228
GLY A 227
GLY A 224
ASP A 233
None
1.16A 1wg8B-5vgrA:
undetectable
1wg8B-5vgrA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CC8_A_RBFA1067_1
(VNG1446H)
5vgr ATLASTIN-3
(Homo
sapiens)
3 / 3 PHE A 231
VAL A 212
TRP A 215
None
0.70A 2cc8A-5vgrA:
undetectable
2cc8A-5vgrA:
11.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CCB_A_RBFA1067_1
(VNG1446H)
5vgr ATLASTIN-3
(Homo
sapiens)
3 / 3 PHE A 231
VAL A 212
TRP A 215
None
0.69A 2ccbA-5vgrA:
undetectable
2ccbA-5vgrA:
11.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VH3_A_DAHA2_1
(RANASMURFIN)
5vgr ATLASTIN-3
(Homo
sapiens)
5 / 9 ALA A 354
SER A 410
PHE A 409
GLY A 405
ALA A 348
None
1.49A 2vh3A-5vgrA:
undetectable
2vh3A-5vgrA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VX9_A_RBFA1064_1
(DODECIN)
5vgr ATLASTIN-3
(Homo
sapiens)
3 / 3 PHE A 231
VAL A 212
TRP A 215
None
0.69A 2vx9A-5vgrA:
undetectable
2vx9A-5vgrA:
11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ETE_B_H3PB552_1
(GLUTAMATE
DEHYDROGENASE)
5vgr ATLASTIN-3
(Homo
sapiens)
3 / 3 TYR A 192
TYR A 332
ILE A 331
None
0.75A 3eteA-5vgrA:
undetectable
3eteB-5vgrA:
1.9
3eteA-5vgrA:
19.85
3eteB-5vgrA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_1
(FIV PROTEASE)
5vgr ATLASTIN-3
(Homo
sapiens)
5 / 10 LEU A  31
ASP A  42
ALA A  45
ILE A  49
VAL A  27
None
1.00A 3ogqA-5vgrA:
undetectable
3ogqA-5vgrA:
14.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P6H_A_IBPA133_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 7 ASP A 233
ILE A 253
VAL A 249
ARG A 250
None
1.10A 3p6hA-5vgrA:
undetectable
3p6hA-5vgrA:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1V_E_URFE1301_1
(URIDINE
PHOSPHORYLASE)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 8 THR A 143
GLY A 118
ILE A 119
VAL A  30
None
0.97A 4e1vE-5vgrA:
2.7
4e1vE-5vgrA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IQQ_B_D16B402_1
(THYMIDYLATE SYNTHASE)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 7 ILE A 178
GLY A 228
PHE A 231
TYR A 299
None
0.77A 4iqqB-5vgrA:
undetectable
4iqqB-5vgrA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IQQ_C_D16C402_1
(THYMIDYLATE SYNTHASE)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 7 ILE A 178
GLY A 228
PHE A 231
TYR A 299
None
0.75A 4iqqC-5vgrA:
undetectable
4iqqC-5vgrA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LNX_A_T44A501_1
(THYROID HORMONE
RECEPTOR ALPHA)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 6 SER A 168
GLN A 206
VAL A 316
THR A 317
None
1.11A 4lnxA-5vgrA:
undetectable
4lnxA-5vgrA:
23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M51_A_BEZA501_0
(AMIDOHYDROLASE
FAMILY PROTEIN)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 6 ILE A 121
SER A 167
PHE A 325
LEU A 321
None
0.89A 4m51A-5vgrA:
undetectable
4m51A-5vgrA:
23.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MK4_B_CHDB502_0
(FERROCHELATASE,
MITOCHONDRIAL)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 6 PHE A 210
ILE A 178
ARG A 235
VAL A 249
None
1.23A 4mk4B-5vgrA:
undetectable
4mk4B-5vgrA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IMS_A_ACTA708_0
(ACETOLACTATE
SYNTHASE CATALYTIC
SUBUNIT,
MITOCHONDRIAL)
5vgr ATLASTIN-3
(Homo
sapiens)
3 / 3 GLY A 110
GLY A 111
GLN A 120
None
0.47A 5imsA-5vgrA:
2.4
5imsA-5vgrA:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NOO_B_D16B402_1
(THYMIDYLATE SYNTHASE)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 7 ILE A 178
GLY A 228
PHE A 231
TYR A 299
None
0.82A 5nooB-5vgrA:
undetectable
5nooB-5vgrA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CB4_A_BEZA501_0
(CANAVALIN)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 8 ASN A 173
VAL A  65
ILE A 171
ARG A 213
None
None
None
GDP  A 501 (-3.7A)
0.79A 6cb4A-5vgrA:
undetectable
6cb4A-5vgrA:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FBP_B_ADNB404_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
5vgr ATLASTIN-3
(Homo
sapiens)
5 / 12 ASP A  78
ILE A  76
ILE A 297
PRO A 268
PHE A  79
None
None
None
GDP  A 501 (-4.0A)
None
1.41A 6fbpA-5vgrA:
undetectable
6fbpB-5vgrA:
undetectable
6fbpA-5vgrA:
13.28
6fbpB-5vgrA:
13.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MN4_E_AM2E301_0
(AMINOGLYCOSIDE
N(3)-ACETYLTRANSFERA
SE, AAC(3)-IVA)
5vgr ATLASTIN-3
(Homo
sapiens)
4 / 7 HIS A 397
THR A 401
HIS A 387
ASP A 396
None
1.33A 6mn4E-5vgrA:
undetectable
6mn4E-5vgrA:
20.56